Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s share price shot up 50% on Friday . The stock traded as high as $0.90 and last traded at $1.35. 103 shares traded hands during trading, a decline of 95% from the average session volume of 1,965 shares. The stock had previously closed at $0.90.
Nutriband Trading Up 50.0%
The company has a 50-day simple moving average of $1.22 and a two-hundred day simple moving average of $1.38.
Institutional Trading of Nutriband
An institutional investor recently bought a new position in Nutriband stock. Clear Street Group Inc. bought a new position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 61,590 shares of the company’s stock, valued at approximately $105,000.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Read More
- Five stocks we like better than Nutriband
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
- 3 ETFs For the Coming Genomics Revolution
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
